Your expert drug development partner, guiding your asset to and through the clinic If you’ve only got one shot at getting your drug to the clinic, we’ll help you make it the best one. At Leads to Development, we enable biotech companies to bring novel drugs to and through clinical trials as efficiently and smoothly as possible. With decades of experience and more than 160 projects under our belt throughout Europe and the US, our team provides comprehensive end-to-end support across all areas of new drug development. Our backgrounds are in biotech rather than big pharma, so we understand the …

109 similar entities Type: SMB Startup Activities: biotech deeptech Technologies: Synthetic Biology

AGV Discovery offers services in chemistry, cell biology, in vitro screening, rational drug design, outsourcing and consultancy. AGV Discovery is a pharmaceutics that specializes in rational design and early development of drug candidates.

61 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

Biomade Peptides We believe that in the near future peptides have found their way into new markets and are a well-known feed stock for better products in life sciences and beyond. NUMAFERM supports you in these developments – from discovery to commercial production.

66 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Science of certainty Founded in 2008, we are a biotech company with two primary areas of business: Preclinical contract research organization (CRO) services and proprietary early target and drug discovery programs. Our focus is the metabolic space (e.g. obesity, diabetes, MASH and gastrointestinal diseases), where we specialize in peptide chemistry, in vivo pharmacology, ex vivo assays, molecular pharmacology, histology, imaging, stereology, NGS (next generation sequencing) and bioinformatics. Gubra is an abbreviation for GUt and BRAin, the original key focus areas of our research and expertise. We work with some of the most interesting and loyal partners and customers from across …

85 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Your CDMO for API Solutions since 1970 | Our excellence, your trust #oeyt At Seratec, APIs are more than a science. They are a passion. Entrepreneurs of pharmaceutical chemistry since 1970, we have produced pharmaceutical active ingredients (APIS) for the treatment of rare and orphaned diseases with internationally recognized French know-how, we design, develop, carry out and record files of pharmacologically active molecules with the American drug (FDA), European (EMA) and National (EMA). To offer the best of the services, we also provide the production of APIs according to quality standards known as good manufacturing practices (BPF 2 or CGMP). …

23 similar entities Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Advancing small and large molecule drug discovery with a multimodal AI platform powered by laboratory automation. 1910 Genetics is the only biotechnology company advancing small and large molecule drug discovery with a multimodal AI platform powered by laboratory automation. We integrate AI with three proprietary data streams – computational data, wet lab proxy biological data, and wet lab ground truth biological data – to deliver novel drug candidates and software solutions to leading pharma and tech partners, and advance our internal pipeline for neurological, autoimmune diseases, and cancer. We are backed by leading investors including M12 - Microsoft's Venture Fund, …

89 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. Data Analytics Synthetic Biology

Transforming protein biologics with groundbreaking high-throughput protein engineering. Avenue Biosciences is a biotechnology company dedicated to accelerating the discovery and development of protein biologics, so that no life-saving therapy goes unrealized because of production barriers. Headquartered in San Francisco, USA, and with laboratory operations in Helsinki, Finland, Avenue Biosciences has developed a protein engineering platform that combines organic biology and machine learning to boost protein production. The proprietary method is based on years of scientific research from the University of Helsinki, Finland. Our goal is to drive significant progress in biotechnology by providing turnkey solutions that streamline production, improve quality, …

142 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Unravelling complex biology with optogenetics, chemistry and computation for small molecule discovery. Our platform is built around a proprietary synthetic biology toolkit, featuring advanced optogenetic tools that enable precise temporal and spatial control of complex pathways and difficult-to-drug targets. Powered by vast proprietary datasets and cutting-edge AI models, our platform accelerates drug discovery and facilitates the generation of novel chemical matter, unlocking solutions for even the most challenging biological systems. biotechnology, aging, drug discovery, machine learning, synthetic biology, optogenetics, artificial intelligence, small molecule, rejuvenation, molecular biology, and novel therapeutics

203 similar entities Type: Startup Activities: deeptech biotech Technologies: A.I. Synthetic Biology A.I. - Machine Learning

Complete genes for complete cures Kano Therapeutics is a biotech startup enabling safe, effective, and flexible correction of gene-length stretches of DNA through a new class of biomaterials: circular single-stranded DNA. By building a “one stop shop” product development platform for single-stranded DNA templates that combines manufacturing, application, and computational tools we bridge the gap between editing genes and totally replacing them. Biotechnology, DNA therapeutics, Gene therapy, CRISPR, and Biological engineering

113 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

GRObio’s groundbreaking science expands the amino acid alphabet to deliver on the promise of protein-based therapies. GRO Biosciences transforms protein therapeutics with new amino acid building blocks to treat incurable diseases. Protein therapeutics, Biologics, and Genomic recoding

99 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Opening the world of biology to new possibilities Element Biosciences is a pioneering life science company democratizing access to advanced biological tools, driving impactful discoveries to benefit humanity. We are focused on developing disruptive DNA sequencing and multiomics technology for research markets. Through innovating every fundamental element of a biological assay system, Element empowers customers with affordable, high-quality data and an improved user experience, which in turn will accelerate scientific discoveries. Next-Generation Sequencers, DNA, and Biotechnology

66 similar entities Type: Startup Activities: deeptech biotech Technologies: Data Analytics

Immunic is a biotechnology company developing small molecule therapies for chronic inflammatory and autoimmune diseases Immunic (Nasdaq: IMUX) is a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases. Privacy Policy: https://imux.com/privacy-policy/

66 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

A Ferring Company working to harness the power of the human microbiome to address unmet medical needs. Rebiotix Inc, part of the Ferring Pharmaceuticals Group, is a clinical-stage biotechnology company revolutionizing the treatment of challenging gastrointestinal diseases by harnessing the power of the human microbiome. Our highly skilled and dynamic team is based out of Roseville, Minnesota. Please feel free to contact us through our website at www.rebiotix.com. Biotechnology, Microbiome, Drug Development, Medicine, Clinical Trials, Regulatory Innovation, Patient Support, Internal Medicine, Manufacturing, Infectious Disease, Gastroenterology, Emerging Diseases, and Novel Technology

64 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

A Biotech Company 100% Focused On Advancing New Therapies For Childhood Cancer A life science company exclusively focused on finding cures for childhood cancer by identifying and developing the most promising projects to create new treatments and drugs. drug development, clinical development, and childhood cancer

295 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Customized phage therapies to eradicate harmful bacteria in chronic diseases BiomX (NYSE America: PHGE) is developing both natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic fibrosis and diabetic foot osteomyelitis. BiomX discovers and validates proprietary bacterial targets and customizes phage compositions against these targets. Microbiome, Biotechnology, Drug Discovery, Phage Therapies, and Pharma

108 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

A WuXi Advanced Therapies company, based in Oxford, UK. OXGENE, a WuXi Advanced Therapies (WuXi ATU) company, based in Oxford, UK, provides cell and gene therapy pioneers around the world with the technologies, automation platforms and service solutions they need to come first in the race to deliver ground-breaking therapeutics. OXGENETM is headquartered in Oxford, UK. For additional information, please visit our website. PRODUCTS: Largest collection of standardised plasmids on the market and SERVICES: DNA Services, Protein Production Services, Virus Services, Cell Line Development Services.

52 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

Our mission is to discover, develop and deliver next generation cancer therapies. G1 Therapeutics, Inc. is a wholly owned subsidiary of Pharmacosmos. Cancer / Oncology, Drug Discovery and Development, and Biotechnology

160 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Delta4 is a Vienna-based biotech startup driving the forefront of digital drug discovery and development. Delta4 is driving the forefront of digital drug discovery and development. We leverage a proprietary computational analytics platform "Hyper-C", combining straightforward biomedical testing and clinical validation of candidate drugs. Our unique approach integrates iterative big data/in silico and experimental screens, offering the most efficient matching of clinical indications and compound/drug effects. drug repositioning, drug discovery, compounds, orphan diseases, indication expansion, AI, and omics

67 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. Synthetic Biology

Taking the Journey Towards Comprehensive Treatment of Serious Disease Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline includes three clinical-stage development programs including an allosteric BCR-ABL inhibitor, a small-molecule GLP-1 receptor agonist, a THR-β agonist and preclinical GIPR modulator programs. For more information, please visit: www.ternspharma.com. Disclaimer: Reposts and posts of contents are for informational purposes only and do not constitute endorsements or promotions of any third-party products, services or organizations (including any statements, views or conducts by such organizations) unless explicitly stated …

71 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Advanced integration of biological systems, math models and artificial intelligence The company, a spin-out of ETH Zurich and the Paul Scherrer Institute, Switzerland, uses high throughput biochemical screening of compounds integrated into an artificial intelligence and cell pathways mathematical modeling process. This platform unlocks previously intractable targets, shortens timelines for drug discovery from years to months and reduces risks. The company focuses on the generation and optimization of drugs which trigger a specific and well characterized effect on signaling pathways, thus leading to higher therapeutic efficacy and reduced risk of toxicity. The company is specialized in GPCR drug discovery and …

113 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Machine Learning Synthetic Biology

Discovery and development of novel therapeutics targeting transcription factors in cancer and other diseases QUANTRO Therapeutics (“QUANTRO”) is a research-based entity that strives to discover and develop novel therapeutics interfering with disease-causing transcriptional programs in cancer and other diseases. QUANTRO will assemble a highly innovative drug-discovery pipeline that employs time-resolved RNA sequencing and comparative transcriptomics to identify and develop drug candidates interfering with transcriptional regulators. The first focus will be on cancer-associated transcription factors, which so far have been unamenable to pharmacologic intervention. QUANTRO was founded as a spin-off of the Institute of Molecular Biotechnology (“IMBA”) and the Research Institute …

61 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Surrozen is a biotechnology company focused on discovering and developing novel regenerative medicines with a focus on unlocking the powerful self-renewal properties of the body through specific control of the Wnt signaling pathway. Surrozen was founded by five leading-edge scientists: K. Christopher Garcia, Ph.D., Roel Nusse, Ph.D. and Calvin Kuo, M.D., Ph.D. from Stanford University; Claudia Janda, Ph.D. from the Princess Maxima Center for Pediatric Oncology; and Hans Clevers, M.D, Ph.D. from the Hubrecht Institute and Princess Maxima Center. Each has conducted extensive research on Wnt signaling, with findings that together shape Surrozen’s technology and approach to therapeutic development. The …

53 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Therapeutics for the Disease of Aging Immune therapy platform targeting Dark Genome antigens that contribute to aging, cancer, diabetes, and neurodegenerative diseases Oncology, Aging, Dark Genome, ALS, Diabetes, and Longevity

198 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Cellular farmers using biotechnology to unlock the full potential of botanical resources. A biotech company dedicated to production of cosmetic ingredients from plant stem cells. We focus on cell cultures of endangered Nordic plants thus using plant biotechnology to make inaccessible treasures accessible. The value we provide is not only a new ingredient - our routine is scrupulous chemical characterisation and efficacy testing to deliver excellent ingredients along with a set of ready-to-use efficacy claims. Cosmetic ingredients, Plant derived active ingredients, In vitro efficacy testing, Anti-ageing ingredients, Skin whitening ingredients, Antioxidants, Plant cell culture, Organic ingredients, and Efficacy claiming

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

French biotech company targeting the Adipocyte to treat insulin resistance, type 2 diabetes and associated comorbidities AdipoPharma SAS is a French biotech company with a US subsidiary committed to understanding the role of the adipocyte cells in diabetes via their unique effect on lipid biosynthesis and management of whole-body lipid homeostasis. Our first-in-class candidate - PATAS - is set to enter clinical trials later this year.

75 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Since more than 10 years, AnyGenes® scientists develop and produce innovative high throughput screening products for signaling pathway analysis. These kits and reagents allow high throughput transcriptomic analysis of a large collection of signaling pathways in many species, biomarkers identification and validation, as well as validation of microarrays results. AnyGenes®, with its innovative & cost effective technologies, products and its proprietary molecular platform, helps scientists to accelerate their projects, publications, and biotech companies for drug development and biomarkers validation. Located in Paris, within Tenon Hospital in the 20th arrondissement, AnyGenes® constitutes a key player in the Biotechnology field. Supported by …

21 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Building a sustainable sector and accelerate the discovery of new treatments tailored to each patient. French consortium to develop new experimental models of cancer in 9 cancer pathologies of interest (Lung, Pancreas, Breast, Liver, Ovary...) 3 major R&D axes: - Developing in vivo models and cell-based assays - Mimicking the human biology by humanizing the tumor microenvironment in mice - Studying the microbiota in cancer patients Oncology, Cancer research, Patient derived Xenograft, Cell lines, Ex vivo assays, Microbiota, Data mining , Translationnal medecine, Humanized mice, Biomarker, Research and Development, In vivo models, Ex vivo models, and Cancer

167 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Children with rare diseases deserve therapeutic answers ORPHELIA Pharma is a French pharmaceutical company based in Paris and Lyon that develops and markets medicines for the treatment of pediatric orphan diseases. ORPHELIA Pharma‘s mission is to provide patients with essential products in the fields of epilepsy and pediatric oncology, with formulations adapted to the pediatric population. With one drug approved in the European Union and one product in late-stage clinical development, ORPHELIA Pharma has recently established regional agreements in the European Union, the USA and China and conducts research projects through academic and industrial partnerships. Neurology, Pediatry, Orphan drug, and …

18 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Molecular biology thought for your needs Biomnigene, a bioanalysis service company, helps prevent potential diseases and to authenticate, trace, secure, validate products and their effects through genetic analysis. Thanks to our expertise, we offer you integrated services for environmental, industrial (pharmaceutical, agro-food, cosmetic) or medical issues such as: - Analysis of the intestinal, skin, vaginal, pulmonary and soil microbiome (16S/ITS metagenomic, shotgun metagenomic, transcriptomic, WGS...). - Identification, quantification and authentication, monitoring of species in a pure sample and in a mixture (microorganisms, viruses, bacteria, meat, fish). - Genotyping - Antibody sequencing and safeguarding of hybridoma lines of special interest; - …

86 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Antineo aims to accompany customers in the preclinical development of novel anticancer agents. We provide services and strategic advice for preclinical development, optimal choice of in vitro and in vivo models as well as strategic input on potential indications to target in the therapeutic landscape. Développement préclinique, in vitro, ex vivo, in vivo, Preuve de concept, Expertise scientifique en pharmacologie, and Modèles à façon

143 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

INNERVATE. SCREEN. PREDICT. NETRI is a technology enabling company that provides human cell based smart assays for high throughput preclinical data acquisition for the neurological Pharma & Cosmetics industries. We provide organs-on-chip solutions & interoperable in vitro models designed to deeply accelerate drug discovery and preclinical trials by mimicking in vivo neural connectivity. neuroscience, microfluidics, neural network, organ on chip, neurofluidics, neurological troubles, Alzheimer, Parkinson, organonchip, dermo-cosmetics, and toxicology

62 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Biopharmalysis is an information site that allows you to make an active watch and follow the strategic developments of companies in the biopharmaceutical sector. With biopharmalysis: • You get a synthetic view of recent news from the sector • You are aware of the latest key agreements and mergers and acquisitions • You follow the clinical and regulatory progress of development products • You have access to the latest subsidies, fundraising and IPOs on the stock market Its five databases have more than 13,000 interactive sheets on agreements, clinical trials, fundraising, mergers/acquisitions and the regulatory life of biopharmaceutical products in …

31 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Depixus SAS, based in Paris, is a life science technology company pioneering a groundbreaking technology based on magnetic force spectroscopy. This innovative technology provides real-time analysis of individual biomolecular interactions at scale, enabling researchers to decode disease mechanisms and unlock faster routes to more effective therapies. Single molecule analysis, RNA Drug Discovery, Protein-protein Interaction Analysis, Biophysics, Drug Discovery, Compound Screening, biomolecular interactions, and interactomics

159 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Leader in advanced optical spectroscopy with solutions dedicated to bioprocess Raman monitoring & laser characterization Leader in bioprocess analytical monitoring, RESOLUTION Spectra Systems is now part of Merck PAT, Raman spectroscopy, Chemometrics, Bioprocess, Bioprocess analytics, Cell culture monitoring, Upstream process development monitoring, Process Analytical Technology, Downstream processes control, In-line monitoring, and Real-time monitoring

38 similar entities Type: Startup Activities: deeptech manufacturing Technologies: Synthetic Biology

New generation microbiome diagnostics for personalised medicine Luxia Scientific is a french start-up company, leading the next wave of breakthrough personalized diagnostics. The company was started by Alessandra Cervino, former research director at Enterome. Luxia scientific is pioneering the development of novel diagnostics based on the genetic analysis of microbiomes. The company has brought to the market it’s first test in Q4 2018 and is developing two additional diagnostics. The Company is affiliated to Medicen and is supported by the BPI, Region Ile de France. Statistics, Biomarkers, Statistical genetics, qPCR, genetics, genomics, microbiome, metagenomics, nutrition, well being, health, probiotics, prebiotics, …

60 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Data Analytics Synthetic Biology

#BeyondInnovation #DermalFiller #CYTOSIAL #AestheticMedicine New ideas, new innovations, new ways of thinking for the medical device industry. We are a pharmaceutical company specialized in the discovery, clinical development, production and commercialization of innovative products in the field of regenerative medicine. At Bioxis Pharmaceuticals, we contribute to transform science into groundbreaking medical device that meet doctors need to improve the health and well-being of their patients in the field of dermatology and aesthetic medicine. Medical Device, Dermatology, Aesthetic, Cosmetic surgery, Regenerative medicine, Ultra-pure chitosan, and Hyaluronic Acid

301 similar entities Type: Startup Activities: healthtech manufacturing deeptech biotech Technologies: Synthetic Biology

33 years of clinical research in pharmacy, medical device & amp; Dermo-cosmetics Quanta Medical Sharing experience Cro since 1986. 30 years of advice and operational services in clinical research and observational studies, 30 years of presence in Europe and on the African continent alongside the pharmaceutical, agro-food, dermatological, cosmetics and medical device, 30 years of human health know -how reinforced by: - a double ISO 9001 & amp; 27001 -dedicated technical tools (Quanta View®, E-CRF, Trial-on-Line®) Clinical research / Clinical trial, E-CRF, Epidemiological Study, Data Management / Biometrics, Medical Writing, Health IT development, Evaluation of health risks, and regulatory advice

249 similar entities Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology

We turn medical devices into clinical reality Neo-Bionica bridges the gap between research and the clinic, providing world-class engineering expertise and links to leading clinicians to create life changing medical device solutions. Offering end-to-end medical device prototype development, from initial concept and rapid prototyping, to pre-clinical testing and first-in-human prototypes for clinical trials

120 similar entities Type: Startup Activities: deeptech healthtech biotech manufacturing Technologies: Synthetic Biology

Supporting Healthcare Innovation R.G.L Research is a contract research organization (CRO) providing expertise and reliable support to the pharmaceutical industries for conducting Clinical Trials. Our clients and partners include pharmaceuticals, biotechnologies, startups, academic and government organization. R.G.L Research is providing tailored and quality services to help clients and partners bend the cost and time curve of drug development to deliver new alternative product and innovative treatment to improve patients quality of life. R.G.L Research has vast professional experience and academic knowledge in performing clinical trials in Israel as well as developing health product in diverse therapeutic areas of medicine, in …

46 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Shaping the future of in vitro preclinical research Unique R&D platform of donor-derived real human adipose tissue ex vivo for pharmaceutical drug development (obesity, chronic metabolic diseases), dermo-cosmetic, nutraceutical, aesthetic and reconstructive surgery research. ExAdEx-Innov owns exclusive worldwide rights to ExAdEx patented breakthrough technology from French academic laboratories of excellence (Côte d’Azur University, Institut de Biologie Valrose, CNRS, INSERM, University Hospital of Nice) and is supported by SATT Sud-Est, IdEX Université Côte d'Azur, CNRS Innovation, Provence Côte d'Azur Business Incubator, Métropôle Nice Côte d’Azur and Eurobiomed Healthtech Accelerator. adipose tissue, cosmetic testing, research platform, in vitro, ex vivo, models, obesity, …

100 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Transforming cancer and autoimmune treatments with unique IL-1RAP targeting approaches Advesya is a pioneering and transformative biotechnology company developing therapies for difficult-to-treat cancers. Haematology & Oncology, Antibody Drug Conjugate, Cell Therapy, and Autoimmune

398 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Dedicated to developing treatments for rare diseases originated from nonsense mutations Genvade aims to harness the power of nonsense mutation readthrough molecules to develop treatments for some of the most burdensome rare diseases. Our lead compound targets indications include cystic fibrosis, Duchenne muscular dystrophy and other genetic diseases. small molecules, drug discovery and development, rare diseases, nonsense mutation corrector, cystic fibrosis, genetic diseases, oncology, readthrough, and Duchenne

101 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Adding Quality Years of Life We are dedicated to improving the lives of patients suffering from hematological malignancies by delivering an innovative immune modulator to enhance the curative potential of allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

207 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Neocor is dedicated to pioneering transformative therapies in cardiac care We are currently developing a novel gene therapy approach targeting ischemic and rare genetic cardiac diseases, and moving from lab preclinical trials to regulatory trials. The Company was founded in October and has received strong traction since inception. We will be looking to strengthen our human and financial ressources in the coming month in order to start the regulatory pre clinical trials. gene therapy, biotechnology, rare disease, and cardiology

118 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Smartox Biotechnology is specialized in peptide research and manufacturing Smartox Biotechnology is specialized in peptide research and engineering. Peptide synthesis, physiology, pharmacology, neuroscience, ion channel research, toxin, venomous animals, and screening library

336 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

AI for digital twin of cells DeepLife is an early stage startup founded in 2019 by Jonathan Baptista and Jean-Baptiste Morlot, backed by international investors, developing the first SaaS platform for Digital Twin of cells. While we are able to design and build incredibly complex mechanical engines, engineering biological systems, such as cells, remains a challenge. However, recent technological improvements, notably in biochemistry, recently enabled the construction of databases with millions of quantitative cell activity measures, covering multiple diseases. The DeepLife team develops a SaaS platform combining state-of-the-art deep learning algorithms on multi-omics sequencing data, public and private cell atlases, …

91 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Deep Learning SaaS

Phenocell is a research-based biotechnology company specialized in the creation, production, and commercialization of cellular models & bioassays for research and drug discovery. We are your designated partner for open innovation projects, let's reach out! Using the Nobel-prize winning technology of cellular reprogramming, we create foot-print free, feeder-free, hiPSC that are further differentiated into somatic cells and amenable to 3D projects. Large batches of qualified cells can be produced and used in unique phenotypic assays to repurpose existing drugs or discover new compounds. Phenocell has specific expertise in the production of: -human skin cells: sebocytes, melanocytes and keratinocytes -human retinal …

67 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

We build high tech equipment supporting end-to-end development and manufacture of cell and gene therapies. We build high tech equipment supporting end-to-end development and manufacture of cell and gene therapies. biotech, medtech, cell therapy, gene therapy, CAR-T, MSC, iPS, ATMP, Tissue Engineering, cell based therapies, biotherapies, RMAT, and Manufacturing

428 similar entities Tags: FrenchTech2030 Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Developing Tomorrow's Antibacterials Antabio is a privately-held clinical-stage biopharmaceutical company developing novel and highly differentiated antibacterial treatments for drug-resistant infections due to CDC and WHO critical priority pathogens. Please visit www.antabio.com and follow us on Twitter @antabio Antibacterial drug discovery, Drug development, and Antibiotic Adjuvant

59 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Orthopedic implants and prosthesis industry with over 36 years of history, trust and transparency. Founded in 1988, Biomecanica is based in Jaú, interior of São Paulo, with one of the most advanced industrial parks in Latin America, Biomechananica has 120 employees, 1,000 products in line, 5,000 sub-items in manufacturing, not to mention the Stars line products. Biomecanica invests in state -of -the -art machining equipment, as well as having a laboratory in its infrastructure, with ISO 7 and ISO 5 certifications (aseptic mode) provided by Anvisa itself for biomaterial production. With the partnership of the most qualified distributors, we reached …

38 similar entities Type: SMB Activities: healthtech Technologies: Synthetic Biology

Bioinnovation at your service. Biomedal S.L is a biotechnology company whose mission is to develop and commercialize new technologies, services and products for research, bioindustry and diagnostics. The company develops its activities in two areas: Biomedal Life Sciences and Biomedal Diagnostics. Biomedal Life Science is devoted to the development and commercialization of products and services for life sciences research, and technology for industrial bioprocesses. Its own technology allowed the improvement of recombinant protein production.Biomedal Life Science also functions as a CRO (Contract Research Organization) and provides services and support to pharmaceutical or biotechnology companies. Biomedal Diagnostics offers a large variety …

102 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

We create pioneering analytical technologies for quality control and performance for the biopharmaceutical industry. ValitaCell is a biotechnology company that creates and commercialises analytical products and technologies for the biopharmaceutical industry. Our products enable clients bring innovative medicines to the market faster, cheaper and with greater regulatory confidence. ValitaCell's vision is to become a pioneer in biological science and cell therapy and to harness the power of artificial intelligence for both applications. ValitaCell is now part of the Beckman Coulter Life Sciences company. Biotechnology , Biologics, Biopharmaceuticals, Bioprocessing, cell therapy, artificial intelligence, and deep learning

Type: Startup Activities: deeptech biotech Technologies: A.I. A.I. - Deep Learning

Inspired by platelet biology to save lives. We engineer and manufacture platelets. platelets, biotechnology, bioengineering, stem cells, on demand, biodrug, in vitro manufacturing, Bioprocess, blood platelets, alloimmunization, thrombocytopenia, blood cancer, leukemia, transfusion, HSCT, Stem cell, Hematology, biologics, drug, biopharma, drug development, healthcare, allogenic therapy, drug delivery, miRNA, siRNA, targeted delivery, and targeted drug delivery

62 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

The Digital Genome Engineering Company Inscripta® is a life science technology company committed to creating a cleaner, healthier, and more sustainable world through biomanufacturing. A global leader in genome engineering, our innovations are designed to unlock the full potential of the bioeconomy. We are committed to the continued development of critical technologies that enable scientists to bolster and expand domestic biomanufacturing, and spur new, safe, and secure biotech innovations. Inscripta supports customers around the world from facilities in Pleasanton and Burlingame, California. To learn more, visit Inscripta.com and follow @InscriptaInc. Digital Genome Engineering, Gene Editing, Synthetic Biology, Genome Editing, CRISPR, …

29 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

We are building the world’s leading predictive simulation of patient biology. Truly meaningful medicine comes from breakthroughs?in deeply understanding patient biology. We are building the world’s first open simulation platform of patient biology. Drug Discovery, Biotechnology, Artificial Intelligence, in silico, Cell Biology, Simulated Experiments, Bioinformatics, and Pharmaceuticals

180 similar entities Type: Startup Activities: deeptech biotech Technologies: A.I. Synthetic Biology

#insilicomeds, #drugdiscovery, #ai, #GANs, #GANs-RL, #DL #aging, #longevity Insilico Medicine, a clinical stage biotech company powered by generative AI, is connecting biology, chemistry, and clinical trials analysis using next-generation AI systems. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. Insilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases. artificial intelligence, deep learning, reinforcement learning, drug discovery, …

57 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Deep Learning Generative A.I. Synthetic Biology

The Medicine Maker celebrates the people, processes and vision that bring new drugs and biologics to market. The development and manufacture of new drugs and biological medicines draws on the talent, passion and experience of a wide range of professionals. The goal of The Medicine Maker is to bring this group into the limelight and, in doing so, to integrate the entire process, from the registration of an Investigational New Drug (IND) or Biologics License Application (BLA) through to the market launch of new therapies, and beyond. pharmaceutical , biopharmaceutical, bioprocess, upstream, downstream, formulation, drug delivery, and dosage form

138 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

The extension of the pharmacist to support good nursing practices Drugoptimal offers software, extension of the pharmacist, deployable in service to caregivers in order to avoid drug-chemical drug incompatibilities (IPC) by detecting the risks on the prescription and by proposing administration solutions to avoid them. Database of 105,000 couples, validated, and developed from a compilation of 22,000 scientific articles, an IPC prediction model by IA (+4000 physico-chemical parameters per couple) and our own research laboratory in analytical chemistry (dedicated broadband platform to analyze more than 1000 samples per day). Our field of action: - Injectable drugs: support for the choice …

30 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology SaaS

Medical cannabis: from seed to purified pharmaceutical grade active ingredients Overseed is the first French biotech company to obtain its license from the ANSM to start its R&D process on cannabis production for pharmaceutical purposes. We are a Biotech which combines leading expertise in genetics, agronomy, organic chemistry and pharma with the ambition to have an expert knowledge on the production of therapeutic cannabis. We will produce GACP and GMP certified dried flowers, full spectrum extracts and purified pharmaceutical grade active ingredients for laboratories. Overseed's research and experimentation will answer patients and the health industry expectations to guarantee production sovereignty, …

58 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

marine-inspired molecules to fight immunological diseases Olgram is a biotechnology company developing first-in-class, proprietary immunotherapies to treat immune deficiencies, beginning with immuno-depression after traumatic brain injury and concussion. Biotechnologie, immunologie, antibiorésistance, and commotions

69 similar entities Type: Startup Activities: deeptech biotech

Advanced molecular analysis technologies to harness the power of the microbiota. To be more responsive, more efficient and make better decisions, BforCure allows public and industrial stakeholders to access biological information in real time, thanks to an innovative technology of rapid biodetection.

68 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Syndivia is committed to enhancing treatment options for cancer patients with solid tumors by leveraging the distinctive properties of targeted DAR1 antibody-drug conjugates, which offer improved tumor penetration, stability, and efficacy. Drug development, Biotechnology, Pharmaceuticals, Antibody-drug conjugates, DAR1 ADC, and ADC

156 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Expertise in protein engineering | in silico & in vitro antibody discovery platform We work in partnership with technology platforms, pharmaceutical companies, and academic research groups to create next generation cell and molecular therapies. We integrate novel technologies into a synthetic antibody platform to provide the most advanced discovery engine possible.

259 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

ADVANCED BY NATURE. Ingenza Ltd. is a boutique, employee-owned CRDMO that develops smarter bioprocesses across life sciences and industrial biotech. With over two decades of experience, Ingenza combines molecular biology, biocatalysis, and computational design into a platform-based approach that enables predictable, scalable, and efficient biomanufacturing. At the heart of our offering are proprietary inGenius platform that drive decision-making and accelerate development: codABLETM – our machine learning-driven gene optimization tool for intelligent codon selection and expression tuning Rapid Strain and Cell Line Development – modular workflows for host selection, expression screening, and stability assessment Integrated Process Development – upstream and downstream …

125 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

The Protein Design Company (TM) - new proteins and biochemistry for the production of valuable sustainable molecules Arzeda, The Protein Design CompanyTM, is a synthetic biology company that creates novel proteins, enzymes and specialty chemical products that compete on performance, cost and sustainability. Partnering with Fortune 500 companies, Arzeda has developed a portfolio of enzymes and specialty chemicals for polymers, pharmaceuticals, industrial chemicals and other advanced applications. More information at www.arzeda.com. Synthetic Biology, Bio-based Chemicals, and Protein Design

95 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Centre d'Etudes Biologiques et Pharmaceutiques OUR MISSION: Provide analytical support for all product development phases (human & veterinary medicines + Medical Device) with: Consulting and expertise Formulation development support Analytical method development and validation Stability studies QC testing Veterinary pre-clinical and clinical studies Développement analytique, Etudes de stabilité, Affaires technico-réglementaires, Consulting & expertise, Troubleshooting (pré et post AMM), Etudes précliniques et cliniques vétérinaires, Analytical method development, ICH validation, Stability study, and Quality Control GMP

95 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Science to Transform Lives Immunocore is a leading T cell receptor (TCR) biotechnology company working to create first-in-class biological therapies to address unmet patient needs in oncology as well as infectious and autoimmune diseases. See our community guidelines: http://bit.ly/2kFA8hr Biotechnology, Cancer, Oncology, Infectious Diseases, Autoimmune Diseases, T Cell Receptor, Immunotherapy, ImmTAX, ImmTAC, ImmTAV, and ImmTAAI

264 similar entities Type: Startup Activities: deeptech hrtech biotech Technologies: Synthetic Biology

Pioneering drug discovery company exploiting cutting edge technologies to create best-in-class small molecule medicines C4XD is a pioneering Drug Discovery company, combining scientific expertise with cutting-edge technologies to efficiently deliver world‐leading medicines. We have a highly valuable and differentiated approach to Drug Discovery through our enhanced molecular design and patient stratification capabilities, generating small molecule drug candidates across multiple disease indications focused on immuno-inflammation. The Company was founded as a spin-out from the University of Manchester. It has a highly experienced management team and Board who have delivered significant value creation within the healthcare sector historically and have enabled C4XD …

59 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

The Supramolecular Chemistry Company Aqdot is a Cambridge (UK)-based supramolecular chemistry company with a focus and expertise in developing, licensing and selling novel proprietary products. The Aqdot Solutions part of the business works in partnership with customers to understand their challenges and develop solutions utilising the unique AqBit technology. This has the team working in areas from air filtering in transportation to delivery of therapeutics for cancer. In parallel the Aqdot Products part of the company has recently launched its own brands AqStarTM M1 and Oderase to date. Again, working with partners either on a distribution basis, or offering the …

29 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

We are a genetics company transforming the way pharmaceutical companies develop drugs to include non-european data. Biomedical research driving transformation in healthcare through genomics. Complete our 3-min survey: https://forms.gle/MFApRSWVno63c1Fx5 Biomedical, Biodiversity, Genome Research, Healthcare, Environment, Conservation, Caribbean, and Biotech

93 similar entities Type: Startup Activities: deeptech biotech Technologies: Data Analytics

Evexta Bio, formerly #Diaccurate, is a biopharmaceutical company exploring the new frontiers of #oncology in search of daring novel therapeutic approaches with the potential to save lives. Now in the clinic, the French biotech is currently developing two proprietary therapeutic assets with novel mechanisms of action across several indications: - Rupitasertib, formerly DIACC3010, an optimized S6K inhibitor with efficient AKT1/AKT3 control of feed-back loop. The oral anti-tumor agent is expected to enter phase 2/3 clinical trial in refractory ER+ HER2- metastatic breast cancer. - EVX020, formerly DIACC2020, an antibody-drug conjugate program using a sole-in-class KIF20A kinesin inhibitor as payload in …

75 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

A clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies. Inventiva is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with significant unmet medical need in the areas of fibrosis, lysosomal storage disorders and oncology. Our research and development programs target indications with substantial unmet medical needs: NASH, MPS and oncology. Drug Discovery, Biotech, Oncology, Fibrosis, Lysosomal Storage Disorders, NASH, and SSc

154 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

RNA Therapeutics We develop first-in-class RNA-based therapies, with lead programs in Head & Neck Squamous Cell Carcinoma (HNSCC) and Facioscalpulohumeral Muscular Dystrophy (FSHD). Our approach to drug design revolves around using genomic patient data to create highly tailored therapeutics – the right drug for the right patient. Our proprietary DREAmiRTM platform utilizes genomic and outcome data from thousands of patients to identify underlying genetic changes that cause their disease, and then creates a novel RNA therapeutic that can directly target and fix that genetic abnormality.

113 similar entities Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology Data Analytics

Inovative company specialized in the development and manufacture of medical devices EOVE develops and manufactures innovatives products to improve care and quality life with greater freedom for Adult ans Pediatric Patients who suffer from breathing disorders and chronic respiratory diseases.

219 similar entities Type: Startup Activities: healthtech manufacturing deeptech Technologies: Synthetic Biology

PepKon is a french biotechnology company founded in 2022. The company develops first-in-class peptides for the treatment of incurable or poor prognosis cancers. These drug-candidates come from over a decade of academic research, resulting in seven scientific publications and two patent families

134 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Contraline is a venture-backed, clinical-stage biotechnology company at the forefront of male contraception. medical device, biotechnology, urology, contraception, womenshealth, reproductivehealth, and menshealth

136 similar entities Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology

A thriving life science community for entrepreneurs and leaders and the ideal environment for businesses to succeed 🧪 Discovery Park is the ideal environment for life science businesses to succeed. From state-of-the-art labs and offices to comprehensive support, we work in partnership with you to provide firm foundations for every stage of your growth. Within easy reach of London, our location provides access to a wealth of resources and opportunities with the freedom to expand, making it the optimal setting for brilliant minds to unlock the potential of scientific breakthroughs. Science, Technology, Manufacturing, Research , Research and Development, Enterprise, Logistics, …

75 similar entities Type: Startup Activities: deeptech manufacturing Technologies: Synthetic Biology

Your safety passport for cosmetic ingredients & drug candidates Your partner for toxicological risk assessment requests Using our digital solutions increases the product safety and reduces the product development cost up by 30%. Insight Biosolutions (IBS) with his expert network has developed specialized platforms for in vitro and in silico services. IBS develops digital tools and services for the cosmetics and pharmaceutical industries. Computational Toxicology, in vitro toxicology , Safety assessment, Drug Discovery, Molecular Modeling, Computational Chemistry, CPSR, Pre Clinical screening, ADME, and PBPK

83 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

CORAL BIOME PHARMA Live cultured corals for Drug discovery Coral Biome is a research and development company dedicated to the discovery of marine natural products of interest for major public health issues such as cancer, inflammation and multi-drug resistant infectious diseases. Our multidisciplinary team of research and worldwide network of collaborators gathers a unique set of competitive expertise including, aquaculture, marine biology, chemistry, cell biology and cancerology to successfully isolate marine natural products and test their biological activity. We maintain a large-scale untapped reservoir of coral species to preserve endangered species, sell corals for aquarium trade (http://www.coralbiome.com/aquaculture/) and provide research …

26 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Expert in microorganism detection & enumeration in the environment C4Hydro is a biotechnology company based out of GRAND LUMINY TECHNOPOLE ZONE LUMINY 163 AVENUE DE LUMINY, MARSEILLE CEDEX 09, France. Biotechnologies, Bactériologie, Légionelle, Legionella pneumophila, Environnement, and Microorganismes

37 similar entities Type: Startup Activities: biotech deeptech cleantech greentech

Natural molecule discovery, industrialized Natural products have contributed more than 500 molecules to pharmaceuticals. However, conventional methods for discovering new natural products are increasingly ineffective. Generare has developed a revolutionary platform that identifies and expresses a wide range of naturally occurring secondary metabolites, selected by millions of years of bacterial evolution. This platform allows us to reintroduce these lead molecules into clinical pipelines, reopening a validated avenue for therapeutic innovation. genomics, synbio, and microbiology

100 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Targeted imaging and therapies Zionexa is an international and innovative company developing and commercializing molecular imaging solutions, in-vivo biomarkers for targeted therapies in oncology, to improve patients’ pathway and bring them a better quality of life. Molecular Imaging, Oncology, Targeted therapies, CDx, Radiopharmaceuticals, and Biomarkers

62 similar entities Type: Startup Activities: biotech deeptech

Dermo-innovation Feeligreen is a technology startup developing safe and effective micro-current devices for a wide range of cosmetic and therapeutic applications. With applications ranging from anti-ageing to wound healing, it develops and sells innovative drug-delivery systems to TIer1 pharmaceutical laboratories medical devices, therapeutics, cosmetics, and skincare

134 similar entities Type: Startup Activities: healthtech manufacturing deeptech biotech Technologies: Synthetic Biology

Innovative medicines to address haemato-oncology related life-threatening and rare diseases ElsaLys Biotech is a specialty pharmaceutical company, part of the Mediolanum Farmaceutici Spa group, focused on innovative medicines to address haemato-oncology related life-threatening and rare diseases. Following strategic acquisitions and targeted developments, ElsaLys is establishing an immunotherapeutic portfolio focused on niche specialty pharmaceuticals to answer unmet medical needs. Our commitment is to offer essential drugs meeting Public Health needs. Founded in 2013, ElsaLys Biotech is located in the heart of the European cluster Lyon Biopole, in Lyon, France. Anticorps thérapeutiques, Anticorps monoclonaux, Therapeutic antibodies, Monoclonal antibodies, ophtalmologie, immune microenvironment, vascular …

59 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

From Sea to Pharmacy ManRos Therapeutics is a biotech company identifying, optimizing and characterizing innovative, low molecular weight kinase inhibitors for the treatment of cystic fibrosis. ManRos was founded in 2007 and is led by Dr Laurent MEIJER, Chairman and CSO, former distinguished Director of Research at the CNRS, and Dr Philippe de Lavenne, CEO, former Vice-President at Actelion Pharmaceuticals. For 40 years, Dr Meijer dedicated his research to the study of protein kinases and their inhibitors, mostly at the CNRS. Drug Development, Cystic Fibrosis, and Biotechnology

60 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Ecrins Therapeutics is a biotechnology company which focuses on the discovery and development of novel anti-cancer compounds from the preclinical phase to phase II clinical proof of concept. In addition to the drug discovery, Ecrins Therapeutics provides a range of products and services for the benefit of our customers in biotechnology companies, universities, public research institutions and in the pharmaceutical industry. The mission of the commercial division of Ecrins Therapeutics is to help medical chemists and drug hunters to discover, characterize and advance their lead compounds through the drug development process. Visit http://ecrins-therapeutics-services.com/ for more information. Our research and production …

47 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Transforming cancer immunotherapy with next generation ADCs Mablink Bioscience is a French biotechnology company that is actively involved in the fight against cancer by bringing disruptive therapeutic solutions. With its Antibody-Drug Conjugates (ADC) masking technology, Mablink Bioscience aims to dramatically improve the efficiency of ADC therapies and accelerate the development of new treatments. Based in Lyon, where it is developing an unprecedented innovation center, Mablink currently has around 30 employees with diverse backgrounds. biotechnology, drug development, drug discovery, oncology, and R&D

70 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

a NOVARTIS company CELLforCURE gathers all cell and gene therapies activities of the LFB group. With an annual production capability of several thousands of therapeutics batches, the Les Ulis CELLforCURE facility is the first modular entity in Europe to enable large scale industrial production for ATMPs. This platform operates on a mixed model of a CDMO (Contract Development and Manufacturing Organisation) providing large scale GMP and cGMP production services, for both clinical and commercial needs, and of a pharmaceutical company leading the development of cell and gene therapies medicinal products up to their launch on the market. CELLforCURE is an …

87 similar entities Type: Startup Activities: healthtech manufacturing deeptech biotech Technologies: Synthetic Biology

Transforming treatment for cancer inflammation viral infection | Unveiling the Translocon to unlock innovative therapies Enodia Therapeutics, a French biotech company, is advancing first-in-class treatment for cancer, inflammatory diseases, and viral infections by targeting the translocon, a key gateway for protein secretion in the cell. Harnessing a cutting-edge AI-driven approach, we are developing selective small molecule inhibitors that block secretion and promote the degradation of pathological proteins at their source. Emerging from the Institut Pasteur and nurtured by Argobio, Enodia is built on breakthrough science with a singular mission: unveiling the translocon to unlock innovative therapies.

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

New therapeutic targets based on arsenic trioxide (As2O3) Founded in 2010, MEDSENIC is a biopharmaceutical start-up that aims to exploit the new possibilities offered by the therapeutic use of arsenic trioxide (As2O3) and thereby provide a treatment for patients with autoimmune diseases. santé, biotechnologies, bioparma, biopharmaceutical, biotech, health, biotechnology, autoimmune diseases, and maladies auto-immunes

346 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Unlocking the power of NIK to transform the future of cancer and autoimmune disease treatment Nikaia Pharmaceuticals, an innovative company dedicated to the discovery and development of cutting-edge therapeutic solutions to improve patients' lives. 🔬💊 Our mission is to push the boundaries of science to deliver novel and effective treatments, focusing on the NIK protein (NF-κB-inducing kinase) and developing molecules capable of blocking its action.

66 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Patient-based drug discovery We design and apply unique patient-based cellular assays for large-scale phenotypic screening, leaning on the power of AI-driven image analysis. Integrated from bed to bench and back to bed, we aim to generate most efficient first-in-class therapeutic molecules for next generation medicine. AI image and data analysis, biology, high content screening, high throughput screening, deep learning, assay development, patient stratification, pyschiatric disorders, and cardiac muscle

235 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: A.I. Synthetic Biology

Fapon is a global leading life sciences company dedicated to providing integrated solutions and services for diagnostics, biopharma and biotherapy. Integrating a one-stop solution on raw materials, reagents and innovative open instrument platforms, the Company has grown into a leading supplier in in-vitro diagnostics. Fapon boasts advanced innovations in therapeutics technologies and AI algorithm platforms with data insights that contribute to a better and healthier world. Supported by its strong global R&D, manufacturing, sales and service network, Fapon's products have established presence in 68 countries and regions, serving more than 2,500 business partners worldwide. biotechnology, Chemiluminescence Immunoassay, NGS, PCR, biological …

34 similar entities Type: SMB Activities: deeptech Technologies: A.I. Synthetic Biology

Enabling Success Sygnature Discovery, headquartered in Nottingham (UK), is a world-leading contract research organization for drug discovery. Based in the UK (Nottingham, Alderley Park, Macclesfield, Glasgow) and Canada (Montreal, Laval, Quebec) and with a staff of over 1,000, including over 900 scientists, Sygnature Discovery partners with the global pharmaceutical industry, biotechs and NfP organizations wishing to outsource part of their R&D work. Since 2004, Sygnature Discovery has delivered more than 56 new preclinical compounds, 29 clinical compounds and 1 registered, thanks to the talents of its world-class scientists, who are named on more than 500 patents. The services offered to …

59 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Liminal BioSciences is a development-stage biopharmaceutical company focused on the discovery and development of novel distinctive small molecule therapeutics that modulate G protein-coupled receptor (GPCR) pathways. The company is developing new proprietary small molecule therapeutic candidates with the intention of developing best-in-class therapeutics for the treatment of unmet metabolic, inflammatory and fibrotic diseases, using its integrated drug discovery platform, expertise in medicinal chemistry and deep understanding of GPCR biology. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. See our social media community guidelines at https://liminalbiosciences.com/social-media-community-guidelines/

72 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

CRO specialized in pharmaceutical drugability for research Expertise in Human and Animal health solid form characterization and formulation development. We deliver both experimental support and consulting services to biotechnology and pharmaceutical companies, not-for-profit organizations and complementary CROs. We are member of the association AFSSI, 1st French research center in Life Sciences, as a founding member and member of the board of Directors. Since March 2019 Joel Vacus, Drugabilis CEO & CSO, is vice-President of AFSSI. https://www.afssi.fr/ Feel free to contact us in order to exchange about your preclinical drug development! contact@drugabilis.com Lead optimization, Formulation, and Physical form optimization

66 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Cellvax, founded in 2001, is a preclinical biotech company which provides in vitro and in vivo studies allowing accelera Cellvax, founded in 2001, is a preclinical CRO which provides innovating drug validation studies both in vitro and in vivo allowing to accelerate the drug development process for unmet needs related to severe human diseases, mainly in Cancer and Osteoarthritis (OA) fields. Cellvax is a fast-growing technology-driven preclinical service company. Today, Cellvax directly employs and through R&D collaborations motivated and differently skilled scientists and engineers, working in interdisciplinary teams on several innovative products. Preclinical studies CRO, Animal models, Cancer, Osteoarthritis, Bio-markers, …

64 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

A MULTI-SKILLED, STRATEGIC AND OPERATIONAL PARTNER IN CLINICAL RESEARCH AND DEVELOPMENT A MULTI-SKILLED, STRATEGIC AND OPERATIONAL PARTNER IN CLINICAL RESEARCH AND DEVELOPMENT ATLANSTAT offers a comprehensive range of research and clinical development services to the human and veterinary pharmaceutical industries, agri-food, biotechnology and medical device companies. As a true partner, ATLANSTAT works closely with its clients to find solutions for the challenges they face to achieve their scientific and regulatory objectives. CRO, Biostatistics, Biotechnology, Medical devices, Data management, Clinical Research, Clinical Operations, Clinical Monitoring, Medical Writing, and Data Science

46 similar entities Type: SMB Activities: biotech deeptech Technologies: Data Analytics

Contract Research Organisation CLINACT, a MultiHealth Group company, is a Contract Research Organisation (CRO) assisting you in your health products development: pharmaceutical, medical devices, biotechnology, cosmetics, nutrition... With more than 20 years of experience, CLINACT provides its expertise for large range of innovative services: - Clinical operations - Biometrics - Medical and regulatory affairs - Pharmacovigilance, medical device vigilance and other vigilances - E-tools : Clinfile - Outsourcing and recruting : TempoPHARMA - Professional Training : FORMATIS This range of services fully covers industrials or academic organisations' requirements. As a MultiHealth company, CLINACT can also provide specific services withtout any …

30 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Peptide Chemistry company for design, synthesis, stability studies and chemical optimisation (SAR studies)- CIR agrement PEPTIDES, PEPTIDE LIBRARIES AND PROTEINS Innovative chemistry for therapeutic, diagnostic and cosmetic applications GENEPEP is a CRO company (with CIR agreement) focused on peptide synthesis & services : - Tools for nanoparticles & surface functionalization - Custom synthesis of peptides, proteins & peptide libraries - Catalog of toxins, peptides & pseudopeptides - Design & synthesis for SAR studies (optimisation of solubility, stability, efficacy,...) - Stability & solubility tests - Partner of European programs, ANR, FUI etc...

375 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology